Cholesterol‐Mediated Metabolic‐mechanotransductive Crosstalk Orchestrates Castration Resistance in Prostate Cancer
Authors:
Open Access
- 4 June 2026
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 13 (48) , e75977
Abstract
Biophysical microenvironment fuels therapeutic resistance, yet the contribution of matrix stiffness to castration‐resistant prostate cancer (CRPC) remains poorly understood. In this study, we established a metabolic‐mechanotransductive crosstalk wherein cholesterol‐driven stromal reprogramming amplifies CRPC progression. Mechanistically, full androgen deprivation (FAD) induces cholesterol metabolic rewiring in prostate cancer (PCa) cells that orchestrates the CH25H‐dependent phenotype transformation of cancer‐associated fibroblast (CAF) into myofibroblastic CAF (myCAF). In turn, the resulting matrix stiffness induces unfolded protein response (UPR) and potentiates IRE1α kinase activity for Xbp1 splicing, while concurrently activating the integrin αVβ3/FAK/STAT3 axis to transcriptionally replenish Xbp1 substrate in PCa cells. This mechanosensitive adaptation thereby confers PCa with resistance to apoptosis induced by FAD. Consequently, pharmacological disruption of this metabolic‐mechanotransductive axis by targeting cholesterol metabolism or blockade of IRE1α‐XBP1s signaling significantly suppress tumor growth, representing a promising therapeutic strategy for CRPC progression.Keywords
Funding Information
- National Natural Science Foundation of China (82220108004)
- National Natural Science Foundation of China (82202933)
- National Natural Science Foundation of China (82504850)
- National Natural Science Foundation of China (82503946)
This publication has 46 references indexed in Scilit:
- STIP1 drives Metabolic Reprogramming in Esophageal Squamous Cell Carcinoma via AHCY‐LDHA AxisExploration, 2025
- Identification of Multi‐Landscape and Cell Interactions in the Tumor Microenvironment Through High‐Coverage Single‐Cell SequencingSmall Methods, 2025
- PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate CancerAdvanced Science, 2024
- Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancerCancer Cell, 2023
- Static and Dynamic: Evolving Biomaterial Mechanical Properties to Control Cellular MechanotransductionAdvanced Science, 2023
- Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapyAdvanced Drug Delivery Reviews, 2022
- Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate CancerCancer Cell, 2020
- Substrate stiffness regulates B‐cell activation, proliferation, class switch, and T‐cell‐independent antibody responses in vivoEuropean Journal of Immunology, 2015
- Androgen‐mediated cholesterol metabolism in LNCaP and PC‐3 cell lines is regulated through two different isoforms of acyl‐coenzyme A: Cholesterol Acyltransferase (ACAT)The Prostate, 2007
- Androgen Deprivation Therapy for Prostate CancerJAMA, 2005